This competitive renewal of the comprehensive Research Training Program in Rheumatic Disease Research at DAB (Director: R.P. Kimberly) builds on established strengths in immunology, immunogenetics and clinical research and incorporates enhanced programmatic emphasis in neuro/behavioral and translational studies. This program centers on interdisciplinary fundamental and clinical research in arthritis and musculoskeletal diseases. The traditional strengths of the UAB Training Program have been enhanced by the formation of collaborative groups and by selective recruitment of faculty in the areas of immunology and inflammation (Chaplin, Chaudry, Matalon), immunogenetics (Allison, Kaslow), neurobehavioral research (Bradley, Barnum, Blalock) and clinical research (Kiefe, Saag). This research base is coordinated through the Arthritis and Musculoskeletal Center (AMC) and consolidated by several key grants, including the MCRC, P01 in SLE, CERTs, GCRG, and ACE. The Clinical Research Training Program (PI: Moreland) provides clinical investigators with the intellectual and administrative skills essential for the design and execution of .informative clinical studies and trials, together with a background in state-of-the-art basic science knowledge. Programmatically, an effective interdisciplinary research experience is implemented by incorporation of required coursework into each individual research plan formulated by the mentor and trainee and by an interdisciplinary enrichment program, both developed in conjunction with Dr. Kimberly and the Executive Committee (Drs. Alarcon, Carter, Kiefe, Moreland, Mountz, and Saag). To provide rigorous and timely oversight of this interdisciplinary program, a series of benchmarks for progress will formulated for each trainee and mentor and will be reviewed by the Program Director and Executive Committee on a semi-annual basis. The overall performance of the Program and its direction will be evaluated annually by the Training Program Advisory Committee (Collawn, Darley-Usmar, Justement, Koopman) and by the Extramural Advisory Committees of the AMC. The performance of the 22 trainees supported in the past 10 years (5 MD, 4 MD/PhD and 13 PhD) is described in detail, and 95% of trainees completing training since 1996 continue in research in industry (1), government (1) and academia (19). Funding is requested for four pre-doctoral and three postdoctoral trainees.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007450-29
Application #
7841854
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Mancini, Marie
Project Start
1982-03-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
29
Fiscal Year
2010
Total Cost
$181,261
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Axtell, Robert C; Raman, Chander; Steinman, Lawrence (2013) Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol 44:114-20
Naves, Rodrigo; Singh, Simer P; Cashman, Kevin S et al. (2013) The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 191:2967-77
Harms, Ashley S; Cao, Shuwen; Rowse, Amber L et al. (2013) MHCII is required for ?-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J Neurosci 33:9592-600
Jones, Nicholas R; Pegues, Melissa A; McCrory, Mark A et al. (2012) A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans. Mol Ther Nucleic Acids 1:e52
Reddy, Timothy E; Gertz, Jason; Crawford, Gregory E et al. (2012) The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genes. Mol Cell Biol 32:3756-67
Sestero, Christine M; McGuire, Donald J; De Sarno, Patrizia et al. (2012) CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J Immunol 189:2918-30
Axtell, Robert C; Raman, Chander (2012) Janus-like effects of type I interferon in autoimmune diseases. Immunol Rev 248:23-35
Reddy, Timothy E; Gertz, Jason; Pauli, Florencia et al. (2012) Effects of sequence variation on differential allelic transcription factor occupancy and gene expression. Genome Res 22:860-9
Hu, Xian-Zhen; Wright, Tyler T; Jones, Nicholas R et al. (2011) Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is Fc?RIIB Dependent. Autoimmune Dis 2011:484936
Jones, Nicholas R; Pegues, Melissa A; McCrory, Mark A et al. (2011) Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice. Arthritis Rheum 63:2641-50

Showing the most recent 10 out of 56 publications